Valneva SE VALN
NASDAQ VALN
$7.00 -0.06 (-0.85%)
As of: Sep 4, 2026 · 1:38 PM EDT

Valneva SE (VALN) Interest & Investment Income (2021 - 2026)

Valneva SE (VALN) posted Interest & Investment Income of $615812.2 for Q1 2026, up 175.58% sequentially from -$814830.5 in Q4 2025, and up 14.57% YoY from $537512.9 in Q1 2025.

Analysis

Valneva SE (VALN) Interest & Investment Income (2021 - 2026) Analysis & Trends

Valneva SE has reported Interest & Investment Income for 6 years, with the latest figure at $615812.2 in Q1 2026.

  • Quarterly Interest & Investment Income rose 14.57% year-over-year to $615812.2 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.0 million (down 28.25% YoY) and the FY2025 annual result came in at -$3.0 million, down 16.51% from the prior year.
  • Interest & Investment Income improved to $615812.2 in Q1 2026 per VALN's latest filing, from -$814830.5 in the prior quarter.
  • Over five years, Interest & Investment Income peaked at $627105.7 in Q2 2025 and troughed at -$3.5 million in Q3 2025.
  • A 5-year average of -$208438.2 and a median of $239489.9 in 2023 frame the typical range for Interest & Investment Income.
  • The sharpest annual moves came in 2022 and 2024: Interest & Investment Income surged 1891.79% in 2022, then slumped 1057.03% in 2024.
  • Over 5 years, Interest & Investment Income stood at $205069.7 in 2022, then jumped by 154.99% to $522906.8 in 2023, then slumped by 324.79% to -$1.2 million in 2024, then soared by 30.68% to -$814830.5 in 2025, then surged by 175.58% to $615812.2 in 2026.
  • According to Business Quant data, Interest & Investment Income over the past three periods registered $615812.2, -$814830.5, and -$3.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Vertex Pharmaceuticals 139.26 Bn 131.41 Bn 2.84 Bn 120.60 Mn
2 Regeneron Pharmaceuticals 85.64 Bn 77.64 Bn 3.93 Bn -48.00 Mn
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn 48.00 Mn
4 Moderna 57.83 Bn 52.69 Bn 52.00 Mn 67.00 Mn
5 Revolution Medicines 44.08 Bn 44.08 Bn - 35.58 Mn
6 BeOne Medicines 39.94 Bn 34.84 Bn 1.53 Bn 27.90 Mn
7 Alnylam Pharmaceuticals 35.19 Bn 31.88 Bn 992.69 Mn 28.14 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn - 5.13 Mn
9 Insmed 27.35 Bn 26.19 Bn 358.27 Mn 10.98 Mn
10 Valneva SE 588.63 Mn 447.37 Mn 1.86 Mn 620,701.23
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 620,701.23
Mar 31, 2026 615,812.21
Dec 31, 2025 -814,830.46
Sep 30, 2025 -3.47 Mn
Jun 30, 2025 627,105.67
Mar 31, 2025 537,512.95
Dec 31, 2024 -1.18 Mn
Sep 30, 2024 -2.29 Mn
Jun 30, 2024 561,058.43
Mar 31, 2024 288,972.23
Dec 31, 2023 522,906.80
Sep 30, 2023 239,489.90
Jun 30, 2023 273,320.02
Mar 31, 2023 271,555.48
Dec 31, 2022 205,069.72
Sep 30, 2022 24,198.58
Jun 30, 2022 23,475.25
Mar 31, 2022 14,590.39
Dec 31, 2021 10,295.74
Sep 30, 2021 14,151.45